From infectious disease to personalized cancer vaccines: Regulatory T cell epitopes determine patient outcomes and suppress neoantigen responses
EpiVax_Oncology_Ancer_SITC_05Nov18_39Wx35H
Disease Status Explained by Neo-epitopes with Low Potential for Activating Regulatory T cells: an Application of Precision Cancer Immunotherapy Design Tools to Bladder Cancer
EpiVax_poster_Disease Status Explained by Neo-Epitopes with Low Potential for Activating Regulatory T Cells